IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Recent Updates — PAHC

August 26, 2026View Source ↗

Phibro Animal Health Corporation reported fourth quarter and fiscal year 2026 results, announcing record full-year net sales of $1,518.1 million, a 17% increase, driven by the MFA acquisition and strong demand in Animal Health and Mineral Nutrition segments. Full-year diluted EPS rose 48% to $3.22 on adjusted basis, while Adjusted EBITDA increased 39% to $255.0 million. The company provided fiscal year 2027 guidance projecting net sales of $1.55 billion to $1.60 billion and Adjusted EBITDA of $258 million to $268 million. Additionally, Phibro announced the planned closure of its Chicago Heights manufacturing facility by summer 2027 as part of a strategic network consolidation following the MFA acquisition, affecting approximately 100 employees. The company operates in the animal health and mineral nutrition industry.

July 28, 2026View Source ↗

Phibro Animal Health Corporation declared a quarterly cash dividend of $0.12 per share on its Class A and Class B common stock. The dividend is payable on September 23, 2026, to stockholders of record at the close of business on September 2, 2026. This announcement was made via a press release filed as Exhibit 99.1 to the current report. Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company providing solutions to livestock producers, farmers, veterinarians, and consumers.

June 26, 2026View Source ↗

Phibro Animal Health Corporation announced the appointment of Daniel (Dani) Bendheim as Chief Executive Officer and President, effective July 1, 2026. Under his new employment agreement, Mr.. Bendheim will receive an annual base salary of $850,000, a target annual discretionary bonus of 50% of base salary, and target annual time-vesting RSUs with a target value of approximately 50% of base salary. Additionally, he was granted 300,000 performance-based RSUs that vest on June 30, 2031, based on the 90-Day Average closing stock price per share between $70 and $100. Phibro Animal Health Corporation operates in the animal health industry, providing products and services for livestock and companion animals.